CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Medscape Medical Affairs has been recognized by Life Sciences Review Magazine as the exclusive recipient of “Top 10 Medical Affairs Services Companies - 2024,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Life Sciences Review research and editorial team based on insights from an interview with Christina Hoffman, Global Head.

Medscape Medical Affairs
Catalyzing Clinical Innovation

Medscape Medical Affairs

Christina Hoffman, Medscape Medical Affairs | Life Science Review | Top Medical Affairs Services CompaniesChristina Hoffman, Global Head
Medical affairs is pivotal for pharmaceutical innovation, driving the integration of life-changing therapies into clinical practice to improve patient care. The primary goal of medical affairs teams is to ensure that healthcare professionals (HCP) can access the most accurate, relevant and up-to-date medical information. To achieve this, they must gain insights about information-seeking behaviors across various channels and touchpoints and deliver content that is personalized, engaging and impactful.

Medscape Medical Affairs, a pioneering force in the industry, excels in this mission. The company is more than a provider of exceptional medical-led content. It adeptly delivers two vital components; actionable insights and an omnichannel engine, both crucial for guiding decision-making in clinical settings.

Building on a legacy spanning three decades, Medscape is a trusted professional medical information site, which houses the world’s largest professional network of clinicians, including 6.5 million MDs and 10.5 million HCPs. Analyzing their content consumption pattern, medical affairs teams can gain actionable insights into trends, preferences and information needs to better plan for upcoming educational initiatives and campaigns.

The company fulfills its commitment to providing omnichannel capabilities for the medical community by leveraging the powerful digital engagement and marketing platform of its parent company, Internet Brands.

“We are a source of authority for creating quality medical-led content. But our superpower lies in channeling the right HCPs to the right content to improve patient care in everyday practices,” says Christina Hoffman, global head of Medscape Medical Affairs.

A MULTI-PRONGED APPROACH TO CONTENT CURATION

Hoffman brings more than 15 years of in-depth experience in product launch readiness. Her multifaceted skill set across B2B and B2C communications, healthcare IT, market research, andragogy, KOL identification, and analysis is instrumental in extracting actionable insights from oceans of data.

A primary challenge for medical affairs teams is the lack of clarity on what makes an insight actionable. As HCPs use Medscape’s vast data repository, a multitude of interactions generates insights into their consumption behaviors. Direct contact with these members empowers clients to understand the type of content they interact with, including the length of time, the most frequently accessed resources, and in what manner.

This allows them to gauge how HCPs consume the information and best serve their areas of interest.

“We have an impressive membership because clinicians worldwide trust and rely on our site for the truth in medical information and clinical practice patterns,” says Hoffman.

Every member of the clinician group receives information through multiple channels and platforms in a distinct way and at preferred times. Medscape’s omnichannel engine enables medical affairs teams to reach HCPs where they are most active and engage them through their preferred channels, like digital platforms, conferences or publications.

Medscape’s distinctive feature is content optimization. Rather than posting lengthy content, it suggests a strategic approach to condense and create concise versions that resonate with the target audience.

We are a source of authority for creating quality medical-led content. But our superpower lies in channeling the right HCPs to the right content to improve patient care in everyday practices


In one instance, Medscape rolled out a multifaceted content strategy to gauge audience engagement. Three content formats were developed based on a single symposium. The initial piece of content featured the complete symposium. In the second version, the content was divided into four chapters, while the third format comprised handpicked excerpts from those chapters.

Centering on behavioral analysis, Medscape assessed the extent and depth of engagement, providing medical affairs teams with insights into whether or not they progressed through the materials. Discerning their pattern provided them with a nuanced understanding of the overall success of the content and areas that resonated most with the audience.

MEASURING IMPACT THROUGH KPI

Aside from these content engagement strategies, it is paramount for medical affairs divisions in pharmaceutical companies to measure the success of clinical initiatives. Medscape emphasizes articulating key performance indicators (KPI)—leading and lagging—to evaluate HCP progression upfront, ensuring alignment with overall strategic goals.

The onboarding process begins with defining the client’s area of interest, like disease state education, symposia, webinars and podcasts. After determining the KPIs and other metrics, Medscape devises strategies to maximize the content’s impact to influence the KPI.

More than the ‘clicks’ of interactions, medical affairs professionals can monitor HCPs’ information-seeking behaviors and shifts in crucial early indicators, such as knowledge, confidence and perception. This allows them to compare responses before and after exposure so that the content strategy is on track. Based on the HCP’s response to the proposed content, they can assess its impact on different audience groups, which helps in refining future segmentation efforts.

Illustrating Medscape’s intent to drive impactful outcomes is a partnership with Sanofi, a French multinational pharmaceutical and healthcare company. The collaboration aimed to implement a curriculum of training activities within the cardiovascular (CV) therapeutic area to address three pre-defined KPIs over two years.

Medscape developed a comprehensive medical-led content strategy to demonstrate tactics specific to multi-specialty audiences for achieving certain KPIs. It evaluated the impact of various activities at the three- and six-month marks post-exposure. Analysis revealed that certain content pieces were more effective in different audience subsets, such as cardiologists versus primary care physicians. This insight prompted Sanofi’s CV medical affairs team to focus its training on individuals with the greatest impact. The success of this initiative led to increased investment and continued partnership with Medscape.

A commitment to disrupting ‘at-risk’ collaborations with medical affairs teams includes taking on shared financial responsibility. Medscape is venturing into outcomes-based agreements dependent on pre-established KPIs.

  • We have an impressive membership because clinicians worldwide trust and rely on our site for the truth in medical information and clinical practice patterns


In a team-up with Eli Lilly, a prominent American pharmaceutical company, Medscape developed a risk-based model tailored to meet their objectives. It actively engaged with the client and continuously monitored the model’s impact. This ongoing continuous assessment led to the teams iteratively refining strategies to ensure they accomplish the KPI goals.

JOURNEY TOWARD HEALTHCARE TRANSFORMATION
Medscape follows a pragmatic approach, standing ready to customize solutions for medical affairs teams to meet their specific requirements.

A notable instance involved a client hosting a live symposium where the attendance was low. A high slot fee appeared to be the issue. Medscape proposed a more cost-efficient way of reaching a larger audience—recording a free webinar that conveys the same content and insights. The primary goal was to broaden the reach and impact of the symposium. Opting for this approach, the client maintained a huge presence at the conference with their booth and medical affairs teams. This strategic adjustment also resulted in substantial cost savings of around $50,000.

Continuous quality evaluation and refinement are integral to Medscape. It ensures each initiative is impactful and applies the knowledge gained from previous experiences to future endeavors.

Medscape envisions delivering on the promise for medical affairs teams to be a strategic pillar in the pharmaceutical industry alongside clinical development and commercialization teams. It is poised to accelerate novel clinical breakthroughs, shaping the future of healthcare.

Deep Dive

What Sets the Gold Standard in Medical Affairs Services

Medical affairs leaders now face a challenge that extends far beyond producing scientifically credible content. They must support clinical understanding across fragmented digital environments, engage the right healthcare professionals without overburdening field teams and demonstrate that educational activity leads to measurable impact rather than simple exposure. Traditional medical communications can still generate polished materials, but organizations increasingly need partners capable of connecting scientific insight, engagement strategy and outcomes measurement within a single accountable framework. The pressure is particularly strong in healthcare, where physician access is fragmented and tolerance for generic outreach continues to decline. Clinicians may engage with congress coverage, peer discussion, clinical updates or disease-state education at very different moments, and poorly timed communication often becomes background noise. Effective providers must understand how healthcare professionals consume information, which formats maintain attention and how scientific content fits into real clinical decision-making. Scale alone does not create value. Reach only matters when it is precise enough to place relevant education in front of clinicians most likely to apply it in practice. That makes audience intelligence a central consideration in procurement decisions. Medical affairs organizations should prioritize partners capable of identifying learning gaps, segmenting healthcare professionals by specialty and interest and adapting educational pathways to the ways clinicians actually engage with information. Stronger engagement models do not treat education as a single asset distributed across multiple channels. Instead, they build structured sequences in which content, timing and delivery format are guided by evidence about audience behavior. Personalization must also remain disciplined so that it clarifies the educational journey rather than overwhelming clinicians with excessive communication across every available channel. Measurement is equally important. Senior decision-makers should be cautious of engagement reports focused only on impressions, clicks or attendance figures. Those metrics may demonstrate reach, but they rarely prove whether knowledge, confidence or clinical behavior has changed. The more valuable partners establish baseline understanding, track participation, evaluate learning outcomes, monitor change over time and, where appropriate, connect educational activity to real-world indicators. This matters because medical affairs teams are often expected to justify investment without reducing scientific engagement to purely commercial metrics. Stronger measurement frameworks allow organizations to demonstrate scientific value, accountability and patient-relevant progress while preserving the non-promotional role of medical affairs. The strongest providers also operate consultatively. Effective medical education programs begin with the sponsor’s therapeutic priorities, target audiences and intended behavioral changes, then evolve through scientific expertise and channel strategy. Buyers should favor partners willing to challenge weak assumptions while still allowing medical affairs teams to retain strategic ownership. This balance becomes especially important for multinational programs where cultural expectations, language requirements and regional practice patterns influence how education should be designed and delivered. Medscape Medical Affairs stands out for organizations seeking this combination of audience reach, engagement intelligence and measurable impact. Its capabilities include healthcare professional membership insights, advisory-board-supported input, disease-state education, guaranteed enduring engagement and publication amplification for peer-reviewed literature. The broader engagement model also incorporates content strategy, targeted audience segmentation, access to clinicians across more than 30 specialties and outcome-focused measurement. Its platform further benefits from a data-informed engagement engine, personalization driven by extensive healthcare professional signals and a structured five-stage framework for measuring educational impact. For organizations seeking medical education programs that reach the right clinicians and demonstrate meaningful effect, Medscape Medical Affairs represents a strong choice. ...Read more
Top 10 Medical Affairs Services Companies - 2024
Current Issue

Company : Medscape Medical Affairs

Management
Christina Hoffman, Global Head

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://medical-affairs.lifesciencesreview.com/vendor/catalyzing-clinical-innovation-cid-1560-mid-157.html